These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 3245619)
41. [The clinical efficacy of plasmapheresis in the combined therapy of patients with chronic glomerulonephritis and nephrotic syndrome]. Kolesnik NA; Dudar' IA; Velichko MB Urol Nefrol (Mosk); 1993; (6):44-6. PubMed ID: 8160322 [TBL] [Abstract][Full Text] [Related]
42. [Effect of cardiac glycosides and anabolic preparations on the indices of the blood oxygen balance and carbohydrate metabolism in ischemic heart disease patients in the initial (preclinical) stage of heart failure]. Denisiuk VI; Shkliar MB Ter Arkh; 1984; 56(4):64-7. PubMed ID: 6729733 [No Abstract] [Full Text] [Related]
43. Successful management of hypokalaemia related conduction disturbances in acute aluminium phosphide poisoning. Kochar DK; Shubhakaran ; Jain N; Sharma BV; Meena CB J Indian Med Assoc; 2000 Aug; 98(8):461-2. PubMed ID: 11294330 [TBL] [Abstract][Full Text] [Related]
44. [Erythrocyte aggregation and the blood rheological properties in chronic ischemic heart disease]. Progonnaia VV; Romanenko AI Vrach Delo; 1980 Oct; (10):54-7. PubMed ID: 7434707 [No Abstract] [Full Text] [Related]
45. [Radon therapy in the complex treatment of patients with ischemic heart disease and hypertension at the Belokurikha health resort]. Nikitin IuP; Naumova EN; Rynkova GI; Liutova FF; Filimonova TA Vopr Kurortol Fizioter Lech Fiz Kult; 1985; (1):13-5. PubMed ID: 3984247 [No Abstract] [Full Text] [Related]
46. [Clinical effectiveness of plasmapheresis in patients with unstable stenocardia refractory to drug therapy]. Kukharchuk VV; Karpov IuA; Kutsenko AI; Noeva EA; Zaruba AIu Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(2):48-51. PubMed ID: 3426819 [TBL] [Abstract][Full Text] [Related]
47. [Clinico-immunological assessment of the effectiveness of plasmapheresis in the combined therapy of patients with high arterial hypertension]. Legkonogov AV; Kukharchuk VV; Osipov SG; Kutsenko AI Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):25-9. PubMed ID: 3606831 [TBL] [Abstract][Full Text] [Related]
48. [Computerized assistance in the diagnosis and therapy of changes in acid-base and water-electrolyte balance]. Ponce P; Ponce P Acta Med Port; 1983; 4(11-12):485-90. PubMed ID: 6666683 [No Abstract] [Full Text] [Related]
49. [3 dangerous electrolyte disturbances: hyponatremia, hyperkalemia and hypomagnesemia]. Krapf R Schweiz Med Wochenschr; 1993 Apr; 123(15):739-48. PubMed ID: 8488378 [TBL] [Abstract][Full Text] [Related]
50. [Properties of thrombocytes in patients with ischemic heart disease]. Sopina NV Vrach Delo; 1987 Apr; (4):39-41. PubMed ID: 3617634 [No Abstract] [Full Text] [Related]
51. [Correction of intraoperative disorders of hemostasis during aortocoronary bypass in patients with chronic ischemic heart disease]. Kurochkin VM; Iagudina DN; Soboleva ER; Berdichevskiĭ MS Anesteziol Reanimatol; 1988; (2):21-4. PubMed ID: 3261556 [No Abstract] [Full Text] [Related]
52. Fluid and electrolyte and drug therapy considerations in the management of eating disorders. Comerci GD Semin Adolesc Med; 1986 Mar; 2(1):37-46. PubMed ID: 3602624 [No Abstract] [Full Text] [Related]
53. Long term effect of LDL apheresis on coronary heart disease. Donner MG; Richter WO; Schwandt P Eur J Med Res; 1997 Jun; 2(6):270-4. PubMed ID: 9182655 [TBL] [Abstract][Full Text] [Related]
54. [Aspects of the mechanism of action of Arzni carbonate mineral waters in ischemic heart disease]. Topchian ZhS; Asatrian AB; Agaronian OSh; Oganova EA; Oganesian EA Vopr Kurortol Fizioter Lech Fiz Kult; 1981; (5):34-7. PubMed ID: 6458155 [No Abstract] [Full Text] [Related]
55. [Effect of combined treatment including Arzni carbonate mineral baths on the glycolipid level of the blood of ischemic heart disease patients]. Asatrian AB; Mkheian EE; Sarkisova GM Vopr Kurortol Fizioter Lech Fiz Kult; 1983; (3):46-7. PubMed ID: 6226148 [No Abstract] [Full Text] [Related]
56. [Atypical electrolytic disorders in patients with diseases of the blood system]. Galstian GM; Shulutko EM; Bulanov AIu; Prasolov NV; Kulimova EB; Kuz'mina LA; Tiurina NG; Pustovoĭt IaS; Model SV Ter Arkh; 2000; 72(7):63-6. PubMed ID: 10983325 [TBL] [Abstract][Full Text] [Related]
57. [Erythrocytic hemostasis and microcirculation in patients with chronic ischemic heart disease]. Topchiĭ II; Volkov VI; Kozhemiaka VA; Tseluĭko VI; Gladchenko AR Vrach Delo; 1985 Mar; (3):21-5. PubMed ID: 4013155 [No Abstract] [Full Text] [Related]
58. [The evaluation of the efficacy of hemosorption and plasmapheresis in IHD complicated by chronic heart failure]. Koriakova NN; Rozhdestvenskaia ED; Zlokazov VB Ter Arkh; 1996; 68(5):71-3. PubMed ID: 9082607 [TBL] [Abstract][Full Text] [Related]
59. [Lipid composition of mononuclear and polymorphonuclear leukocytes from peripheral blood of patients with chronic ischemic heart disease]. Zhukhorov LS Vopr Med Khim; 1983; 29(2):11-3. PubMed ID: 6858027 [TBL] [Abstract][Full Text] [Related]